Morgan Stanley’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.3M | Buy |
|
|||||
|
2025
Q1 | $103M | Buy |
|
|||||
|
2024
Q4 | $109M | Sell |
|
|||||
|
2024
Q3 | $72.6M | Buy |
|
|||||
|
2024
Q2 | $51.2M | Sell |
|
|||||
|
2024
Q1 | $87.2M | Sell |
|
|||||
|
2023
Q4 | $79.3M | Buy |
|
|||||
|
2023
Q3 | $1.31M | Buy |
|
|||||
|
2023
Q2 | $905K | Buy |
|
|||||
|
2023
Q1 | $405K | Buy |
|
|||||
|
2022
Q4 | $364K | Buy |
|
|||||
|
2022
Q3 | $416K | Sell |
|
|||||
|
2022
Q2 | $512K | Buy |
|
|||||
|
2022
Q1 | $188K | Sell |
|
|||||
|
2021
Q4 | $253K | Sell |
|
|||||
|
2021
Q3 | $615K | Buy |
|
|||||
|
2021
Q2 | $241K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $263K | Buy |
|